Get started
CHIA TAI ENTERPRISES INTL LTDCC

CHIA TAI ENTERPRISES INTL LTD

1.64HKDD
−0.08−4.65%
At close at Mar 21, 10:09 GMT
HKD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

3839 fundamentals

Key facts

Market capitalization‪415.46 M‬HKD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)5.01
Basic EPS (TTM)0.34HKD
Founded1987
Employees (FY)900
CEO—
Websitectei.com.hk
About

Chia Tai Enterprises International Ltd. engages in the manufacturing and sale of chlortetracycline products, trading of machinery and manufacturing and sale of automotive parts. It operates through the following two segments: Biochemical Operation and Industrial Operation. The Biochemical Operation segment manufactures and sells chlortetracycline products. The Industrial Operation segment trades machinery; and produces and markets automotive parts, through the joint venture and associate. The company was founded on October 16, 1987 and is headquartered in Hong Kong.

Ownership
‪‪240.72 M‬‬
Closely held shares
‪‪176.35 M‬‬ (73.26%)
Free Float shares
‪‪64.37 M‬‬ (26.74%)
Closely held shares
‪‪176.35 M‬‬ (73.26%)
Free Float shares
‪‪64.37 M‬‬ (26.74%)
Capital structure
Market cap
‪‪415.46 M‬‬
Debt
‪‪537.30 M‬‬
Minority interest
‪‪199.94 M‬‬
Cash & equivalents
‪‪251.53 M‬‬
Enterprise value
‪‪901.17 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪415.46 M‬‬
Price to earning ratio (P/E)
5.01x
Price to sales ratio (P/S)
0.17x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
5.01x
Price to sales ratio (P/S)
0.17x
Valuation ratios
‪0.00‬
‪0.05‬
‪0.10‬
‪0.15‬
‪0.20‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪0.75%‬
‪1.85%‬
‪2.95%‬
‪4.05%‬
‪5.15%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Biochemical
By country
Period: 2024
China
Asia Pacific (excluding Mainland China)
Americas
International
Europe

Dividends

Dividend yield, history and sustainability

3839 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪160.00 M‬‬
‪‪320.00 M‬‬
‪‪480.00 M‬‬
‪‪640.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Assets
Liabilities